首页> 美国卫生研究院文献>other >Use of Integra® and Interval Brachytherapy in a Two-Staged Auricular Reconstruction Following Excision of a Recurrent Keloid
【2h】

Use of Integra® and Interval Brachytherapy in a Two-Staged Auricular Reconstruction Following Excision of a Recurrent Keloid

机译:在切除复发性瘢痕疙瘩的切除后使用Integra®和间歇近距离放射治疗在两个分阶段的耳廓重建中

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Keloids present a formidable clinical challenge. Surgical excision in conjunction with radiation therapy may decrease the chance of keloid recurrence. Split-thickness skin grafts, however, are more prone to failure in the setting of radiation. In this report, we present a patient with a recurrent auricular keloid who underwent excision and immediate Integra® application, followed by high dose rate brachytherapy and interval split-thickness skin graft placement. A 23-year old female with a history of a recurrent auricular keloid after previous surgical excision, corticosteroid injection, and radiation, underwent re- excision of her keloid. Integra® was used to cover the resultant exposed auricular perichondrium. The patient then received high dose rate brachytherapy (1500 cGy) on post-operative days 1 and 2, followed by definitive split-thickness skin graft placement 3 weeks following her initial surgery. The patient recovered from all interventions without complication. There was no evidence of keloid formation 27 months following interval split- thickness skin graft placement at either the auricular recipient or thigh donor sites. We report the first case of two-staged reconstruction of a recurrent auricular keloid (comprised of keloid excision and placement of Integra® in conjunction with high dose rate brachytherapy, followed by subsequent interval split-thickness skin grafting), resulting in an acceptable cosmetic result without evidence of recurrence at long-term follow-up.
机译:瘢痕loid提出了巨大的临床挑战。手术切除加上放射治疗可能会减少瘢痕loid复发的机会。然而,厚薄的皮肤移植物在放射线设置方面更容易失败。在本报告中,我们介绍了一名复发性耳性瘢痕loid患者,该患者接受了切除并立即应用了Integra ®,随后进行了高剂量率近距离放射治疗和间断性增厚皮肤移植。一名23岁的女性,在先前的手术切除,皮质类固醇注射和放疗后,有复发性耳性瘢痕loid病史,并切除了她的瘢痕loid。使用Integra ®覆盖最终暴露的耳廓软骨膜。然后,患者在术后第1天和第2天接受了高剂量率近距离放射治疗(1500 cGy),然后在初次手术后3周进行了明确的厚薄皮肤移植。病人从所有干预措施中恢复过来,没有并发症。在耳廓接受者或大腿供体部位间隔间隔厚度的植皮后27个月,没有瘢痕evidence形成的证据。我们报道了复发性耳廓瘢痕loid的两阶段重建的第一例(包括瘢痕loid切除和Integra ®的放置以及高剂量率近距离放疗,随后进行间隔间断厚度皮肤移植) ,从而获得可接受的美容效果,而长期随访则无复发迹象。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号